Global Bicyclic Peptide Drugs Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Bicyclic Peptide Drugs Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Bicyclic Peptide Drugs by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Bicyclic Peptide Drugs by Country/Region, 2019, 2023 & 2030 2.2 Bicyclic Peptide Drugs Segment by Type 2.2.1 Romidepsin 2.2.2 Phalloidin 2.2.3 Others 2.3 Bicyclic Peptide Drugs Sales by Type 2.3.1 Global Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) 2.3.2 Global Bicyclic Peptide Drugs Revenue and Market Share by Type (2019-2024) 2.3.3 Global Bicyclic Peptide Drugs Sale Price by Type (2019-2024) 2.4 Bicyclic Peptide Drugs Segment by Application 2.4.1 Anti-Cancer 2.4.2 Antibacterial 2.4.3 Others 2.5 Bicyclic Peptide Drugs Sales by Application 2.5.1 Global Bicyclic Peptide Drugs Sale Market Share by Application (2019-2024) 2.5.2 Global Bicyclic Peptide Drugs Revenue and Market Share by Application (2019-2024) 2.5.3 Global Bicyclic Peptide Drugs Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Bicyclic Peptide Drugs Breakdown Data by Company 3.1.1 Global Bicyclic Peptide Drugs Annual Sales by Company (2019-2024) 3.1.2 Global Bicyclic Peptide Drugs Sales Market Share by Company (2019-2024) 3.2 Global Bicyclic Peptide Drugs Annual Revenue by Company (2019-2024) 3.2.1 Global Bicyclic Peptide Drugs Revenue by Company (2019-2024) 3.2.2 Global Bicyclic Peptide Drugs Revenue Market Share by Company (2019-2024) 3.3 Global Bicyclic Peptide Drugs Sale Price by Company 3.4 Key Manufacturers Bicyclic Peptide Drugs Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Bicyclic Peptide Drugs Product Location Distribution 3.4.2 Players Bicyclic Peptide Drugs Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Bicyclic Peptide Drugs by Geographic Region 4.1 World Historic Bicyclic Peptide Drugs Market Size by Geographic Region (2019-2024) 4.1.1 Global Bicyclic Peptide Drugs Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Bicyclic Peptide Drugs Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Bicyclic Peptide Drugs Market Size by Country/Region (2019-2024) 4.2.1 Global Bicyclic Peptide Drugs Annual Sales by Country/Region (2019-2024) 4.2.2 Global Bicyclic Peptide Drugs Annual Revenue by Country/Region (2019-2024) 4.3 Americas Bicyclic Peptide Drugs Sales Growth 4.4 APAC Bicyclic Peptide Drugs Sales Growth 4.5 Europe Bicyclic Peptide Drugs Sales Growth 4.6 Middle East & Africa Bicyclic Peptide Drugs Sales Growth 5 Americas 5.1 Americas Bicyclic Peptide Drugs Sales by Country 5.1.1 Americas Bicyclic Peptide Drugs Sales by Country (2019-2024) 5.1.2 Americas Bicyclic Peptide Drugs Revenue by Country (2019-2024) 5.2 Americas Bicyclic Peptide Drugs Sales by Type (2019-2024) 5.3 Americas Bicyclic Peptide Drugs Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Bicyclic Peptide Drugs Sales by Region 6.1.1 APAC Bicyclic Peptide Drugs Sales by Region (2019-2024) 6.1.2 APAC Bicyclic Peptide Drugs Revenue by Region (2019-2024) 6.2 APAC Bicyclic Peptide Drugs Sales by Type (2019-2024) 6.3 APAC Bicyclic Peptide Drugs Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Bicyclic Peptide Drugs by Country 7.1.1 Europe Bicyclic Peptide Drugs Sales by Country (2019-2024) 7.1.2 Europe Bicyclic Peptide Drugs Revenue by Country (2019-2024) 7.2 Europe Bicyclic Peptide Drugs Sales by Type (2019-2024) 7.3 Europe Bicyclic Peptide Drugs Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Bicyclic Peptide Drugs by Country 8.1.1 Middle East & Africa Bicyclic Peptide Drugs Sales by Country (2019-2024) 8.1.2 Middle East & Africa Bicyclic Peptide Drugs Revenue by Country (2019-2024) 8.2 Middle East & Africa Bicyclic Peptide Drugs Sales by Type (2019-2024) 8.3 Middle East & Africa Bicyclic Peptide Drugs Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Bicyclic Peptide Drugs 10.3 Manufacturing Process Analysis of Bicyclic Peptide Drugs 10.4 Industry Chain Structure of Bicyclic Peptide Drugs 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Bicyclic Peptide Drugs Distributors 11.3 Bicyclic Peptide Drugs Customer 12 World Forecast Review for Bicyclic Peptide Drugs by Geographic Region 12.1 Global Bicyclic Peptide Drugs Market Size Forecast by Region 12.1.1 Global Bicyclic Peptide Drugs Forecast by Region (2025-2030) 12.1.2 Global Bicyclic Peptide Drugs Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Bicyclic Peptide Drugs Forecast by Type (2025-2030) 12.7 Global Bicyclic Peptide Drugs Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Bicycle Therapeutics 13.1.1 Bicycle Therapeutics Company Information 13.1.2 Bicycle Therapeutics Bicyclic Peptide Drugs Product Portfolios and Specifications 13.1.3 Bicycle Therapeutics Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Bicycle Therapeutics Main Business Overview 13.1.5 Bicycle Therapeutics Latest Developments 13.2 Apellis Pharmaceuticals 13.2.1 Apellis Pharmaceuticals Company Information 13.2.2 Apellis Pharmaceuticals Bicyclic Peptide Drugs Product Portfolios and Specifications 13.2.3 Apellis Pharmaceuticals Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Apellis Pharmaceuticals Main Business Overview 13.2.5 Apellis Pharmaceuticals Latest Developments 13.3 Merck 13.3.1 Merck Company Information 13.3.2 Merck Bicyclic Peptide Drugs Product Portfolios and Specifications 13.3.3 Merck Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Merck Main Business Overview 13.3.5 Merck Latest Developments 13.4 Thermo Fisher 13.4.1 Thermo Fisher Company Information 13.4.2 Thermo Fisher Bicyclic Peptide Drugs Product Portfolios and Specifications 13.4.3 Thermo Fisher Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Thermo Fisher Main Business Overview 13.4.5 Thermo Fisher Latest Developments 13.5 ApexBio Technology 13.5.1 ApexBio Technology Company Information 13.5.2 ApexBio Technology Bicyclic Peptide Drugs Product Portfolios and Specifications 13.5.3 ApexBio Technology Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 ApexBio Technology Main Business Overview 13.5.5 ApexBio Technology Latest Developments 13.6 BPS Bioscience 13.6.1 BPS Bioscience Company Information 13.6.2 BPS Bioscience Bicyclic Peptide Drugs Product Portfolios and Specifications 13.6.3 BPS Bioscience Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 BPS Bioscience Main Business Overview 13.6.5 BPS Bioscience Latest Developments 13.7 Selleck Chemicals 13.7.1 Selleck Chemicals Company Information 13.7.2 Selleck Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications 13.7.3 Selleck Chemicals Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Selleck Chemicals Main Business Overview 13.7.5 Selleck Chemicals Latest Developments 13.8 AdooQ BioScience 13.8.1 AdooQ BioScience Company Information 13.8.2 AdooQ BioScience Bicyclic Peptide Drugs Product Portfolios and Specifications 13.8.3 AdooQ BioScience Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 AdooQ BioScience Main Business Overview 13.8.5 AdooQ BioScience Latest Developments 13.9 Cayman Chemical Company 13.9.1 Cayman Chemical Company Company Information 13.9.2 Cayman Chemical Company Bicyclic Peptide Drugs Product Portfolios and Specifications 13.9.3 Cayman Chemical Company Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Cayman Chemical Company Main Business Overview 13.9.5 Cayman Chemical Company Latest Developments 13.10 Santa Cruz Biotechnology 13.10.1 Santa Cruz Biotechnology Company Information 13.10.2 Santa Cruz Biotechnology Bicyclic Peptide Drugs Product Portfolios and Specifications 13.10.3 Santa Cruz Biotechnology Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Santa Cruz Biotechnology Main Business Overview 13.10.5 Santa Cruz Biotechnology Latest Developments 13.11 TargetMol Chemicals 13.11.1 TargetMol Chemicals Company Information 13.11.2 TargetMol Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications 13.11.3 TargetMol Chemicals Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 TargetMol Chemicals Main Business Overview 13.11.5 TargetMol Chemicals Latest Developments 13.12 Abcam 13.12.1 Abcam Company Information 13.12.2 Abcam Bicyclic Peptide Drugs Product Portfolios and Specifications 13.12.3 Abcam Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Abcam Main Business Overview 13.12.5 Abcam Latest Developments 13.13 Biotium 13.13.1 Biotium Company Information 13.13.2 Biotium Bicyclic Peptide Drugs Product Portfolios and Specifications 13.13.3 Biotium Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Biotium Main Business Overview 13.13.5 Biotium Latest Developments 13.14 Cayman Chemical 13.14.1 Cayman Chemical Company Information 13.14.2 Cayman Chemical Bicyclic Peptide Drugs Product Portfolios and Specifications 13.14.3 Cayman Chemical Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Cayman Chemical Main Business Overview 13.14.5 Cayman Chemical Latest Developments 13.15 Apollo Scientific 13.15.1 Apollo Scientific Company Information 13.15.2 Apollo Scientific Bicyclic Peptide Drugs Product Portfolios and Specifications 13.15.3 Apollo Scientific Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Apollo Scientific Main Business Overview 13.15.5 Apollo Scientific Latest Developments 13.16 Tocris Bioscience 13.16.1 Tocris Bioscience Company Information 13.16.2 Tocris Bioscience Bicyclic Peptide Drugs Product Portfolios and Specifications 13.16.3 Tocris Bioscience Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 Tocris Bioscience Main Business Overview 13.16.5 Tocris Bioscience Latest Developments 13.17 Ningbo Inno Pharmchem 13.17.1 Ningbo Inno Pharmchem Company Information 13.17.2 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Product Portfolios and Specifications 13.17.3 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Ningbo Inno Pharmchem Main Business Overview 13.17.5 Ningbo Inno Pharmchem Latest Developments 13.18 Dayang Chemicals 13.18.1 Dayang Chemicals Company Information 13.18.2 Dayang Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications 13.18.3 Dayang Chemicals Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.18.4 Dayang Chemicals Main Business Overview 13.18.5 Dayang Chemicals Latest Developments 13.19 Shanghai Lollane Biological Technology 13.19.1 Shanghai Lollane Biological Technology Company Information 13.19.2 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Product Portfolios and Specifications 13.19.3 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.19.4 Shanghai Lollane Biological Technology Main Business Overview 13.19.5 Shanghai Lollane Biological Technology Latest Developments 13.20 Dalian Meilun Biotech 13.20.1 Dalian Meilun Biotech Company Information 13.20.2 Dalian Meilun Biotech Bicyclic Peptide Drugs Product Portfolios and Specifications 13.20.3 Dalian Meilun Biotech Bicyclic Peptide Drugs Sales, Revenue, Price and Gross Margin (2019-2024) 13.20.4 Dalian Meilun Biotech Main Business Overview 13.20.5 Dalian Meilun Biotech Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Bicyclic Peptide Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Bicyclic Peptide Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Romidepsin Table 4. Major Players of Phalloidin Table 5. Major Players of Others Table 6. Global Bicyclic Peptide Drugs Sales by Type (2019-2024) & (Tons) Table 7. Global Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) Table 8. Global Bicyclic Peptide Drugs Revenue by Type (2019-2024) & ($ million) Table 9. Global Bicyclic Peptide Drugs Revenue Market Share by Type (2019-2024) Table 10. Global Bicyclic Peptide Drugs Sale Price by Type (2019-2024) & (US$/kg) Table 11. Global Bicyclic Peptide Drugs Sale by Application (2019-2024) & (Tons) Table 12. Global Bicyclic Peptide Drugs Sale Market Share by Application (2019-2024) Table 13. Global Bicyclic Peptide Drugs Revenue by Application (2019-2024) & ($ million) Table 14. Global Bicyclic Peptide Drugs Revenue Market Share by Application (2019-2024) Table 15. Global Bicyclic Peptide Drugs Sale Price by Application (2019-2024) & (US$/kg) Table 16. Global Bicyclic Peptide Drugs Sales by Company (2019-2024) & (Tons) Table 17. Global Bicyclic Peptide Drugs Sales Market Share by Company (2019-2024) Table 18. Global Bicyclic Peptide Drugs Revenue by Company (2019-2024) & ($ millions) Table 19. Global Bicyclic Peptide Drugs Revenue Market Share by Company (2019-2024) Table 20. Global Bicyclic Peptide Drugs Sale Price by Company (2019-2024) & (US$/kg) Table 21. Key Manufacturers Bicyclic Peptide Drugs Producing Area Distribution and Sales Area Table 22. Players Bicyclic Peptide Drugs Products Offered Table 23. Bicyclic Peptide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Bicyclic Peptide Drugs Sales by Geographic Region (2019-2024) & (Tons) Table 27. Global Bicyclic Peptide Drugs Sales Market Share Geographic Region (2019-2024) Table 28. Global Bicyclic Peptide Drugs Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global Bicyclic Peptide Drugs Revenue Market Share by Geographic Region (2019-2024) Table 30. Global Bicyclic Peptide Drugs Sales by Country/Region (2019-2024) & (Tons) Table 31. Global Bicyclic Peptide Drugs Sales Market Share by Country/Region (2019-2024) Table 32. Global Bicyclic Peptide Drugs Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global Bicyclic Peptide Drugs Revenue Market Share by Country/Region (2019-2024) Table 34. Americas Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons) Table 35. Americas Bicyclic Peptide Drugs Sales Market Share by Country (2019-2024) Table 36. Americas Bicyclic Peptide Drugs Revenue by Country (2019-2024) & ($ millions) Table 37. Americas Bicyclic Peptide Drugs Sales by Type (2019-2024) & (Tons) Table 38. Americas Bicyclic Peptide Drugs Sales by Application (2019-2024) & (Tons) Table 39. APAC Bicyclic Peptide Drugs Sales by Region (2019-2024) & (Tons) Table 40. APAC Bicyclic Peptide Drugs Sales Market Share by Region (2019-2024) Table 41. APAC Bicyclic Peptide Drugs Revenue by Region (2019-2024) & ($ millions) Table 42. APAC Bicyclic Peptide Drugs Sales by Type (2019-2024) & (Tons) Table 43. APAC Bicyclic Peptide Drugs Sales by Application (2019-2024) & (Tons) Table 44. Europe Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons) Table 45. Europe Bicyclic Peptide Drugs Revenue by Country (2019-2024) & ($ millions) Table 46. Europe Bicyclic Peptide Drugs Sales by Type (2019-2024) & (Tons) Table 47. Europe Bicyclic Peptide Drugs Sales by Application (2019-2024) & (Tons) Table 48. Middle East & Africa Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons) Table 49. Middle East & Africa Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2024) Table 50. Middle East & Africa Bicyclic Peptide Drugs Sales by Type (2019-2024) & (Tons) Table 51. Middle East & Africa Bicyclic Peptide Drugs Sales by Application (2019-2024) & (Tons) Table 52. Key Market Drivers & Growth Opportunities of Bicyclic Peptide Drugs Table 53. Key Market Challenges & Risks of Bicyclic Peptide Drugs Table 54. Key Industry Trends of Bicyclic Peptide Drugs Table 55. Bicyclic Peptide Drugs Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Bicyclic Peptide Drugs Distributors List Table 58. Bicyclic Peptide Drugs Customer List Table 59. Global Bicyclic Peptide Drugs Sales Forecast by Region (2025-2030) & (Tons) Table 60. Global Bicyclic Peptide Drugs Revenue Forecast by Region (2025-2030) & ($ millions) Table 61. Americas Bicyclic Peptide Drugs Sales Forecast by Country (2025-2030) & (Tons) Table 62. Americas Bicyclic Peptide Drugs Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 63. APAC Bicyclic Peptide Drugs Sales Forecast by Region (2025-2030) & (Tons) Table 64. APAC Bicyclic Peptide Drugs Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 65. Europe Bicyclic Peptide Drugs Sales Forecast by Country (2025-2030) & (Tons) Table 66. Europe Bicyclic Peptide Drugs Revenue Forecast by Country (2025-2030) & ($ millions) Table 67. Middle East & Africa Bicyclic Peptide Drugs Sales Forecast by Country (2025-2030) & (Tons) Table 68. Middle East & Africa Bicyclic Peptide Drugs Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. Global Bicyclic Peptide Drugs Sales Forecast by Type (2025-2030) & (Tons) Table 70. Global Bicyclic Peptide Drugs Revenue Forecast by Type (2025-2030) & ($ millions) Table 71. Global Bicyclic Peptide Drugs Sales Forecast by Application (2025-2030) & (Tons) Table 72. Global Bicyclic Peptide Drugs Revenue Forecast by Application (2025-2030) & ($ millions) Table 73. Bicycle Therapeutics Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 74. Bicycle Therapeutics Bicyclic Peptide Drugs Product Portfolios and Specifications Table 75. Bicycle Therapeutics Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 76. Bicycle Therapeutics Main Business Table 77. Bicycle Therapeutics Latest Developments Table 78. Apellis Pharmaceuticals Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 79. Apellis Pharmaceuticals Bicyclic Peptide Drugs Product Portfolios and Specifications Table 80. Apellis Pharmaceuticals Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 81. Apellis Pharmaceuticals Main Business Table 82. Apellis Pharmaceuticals Latest Developments Table 83. Merck Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 84. Merck Bicyclic Peptide Drugs Product Portfolios and Specifications Table 85. Merck Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 86. Merck Main Business Table 87. Merck Latest Developments Table 88. Thermo Fisher Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 89. Thermo Fisher Bicyclic Peptide Drugs Product Portfolios and Specifications Table 90. Thermo Fisher Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 91. Thermo Fisher Main Business Table 92. Thermo Fisher Latest Developments Table 93. ApexBio Technology Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 94. ApexBio Technology Bicyclic Peptide Drugs Product Portfolios and Specifications Table 95. ApexBio Technology Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 96. ApexBio Technology Main Business Table 97. ApexBio Technology Latest Developments Table 98. BPS Bioscience Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 99. BPS Bioscience Bicyclic Peptide Drugs Product Portfolios and Specifications Table 100. BPS Bioscience Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 101. BPS Bioscience Main Business Table 102. BPS Bioscience Latest Developments Table 103. Selleck Chemicals Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 104. Selleck Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications Table 105. Selleck Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 106. Selleck Chemicals Main Business Table 107. Selleck Chemicals Latest Developments Table 108. AdooQ BioScience Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 109. AdooQ BioScience Bicyclic Peptide Drugs Product Portfolios and Specifications Table 110. AdooQ BioScience Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 111. AdooQ BioScience Main Business Table 112. AdooQ BioScience Latest Developments Table 113. Cayman Chemical Company Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 114. Cayman Chemical Company Bicyclic Peptide Drugs Product Portfolios and Specifications Table 115. Cayman Chemical Company Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 116. Cayman Chemical Company Main Business Table 117. Cayman Chemical Company Latest Developments Table 118. Santa Cruz Biotechnology Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 119. Santa Cruz Biotechnology Bicyclic Peptide Drugs Product Portfolios and Specifications Table 120. Santa Cruz Biotechnology Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 121. Santa Cruz Biotechnology Main Business Table 122. Santa Cruz Biotechnology Latest Developments Table 123. TargetMol Chemicals Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 124. TargetMol Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications Table 125. TargetMol Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 126. TargetMol Chemicals Main Business Table 127. TargetMol Chemicals Latest Developments Table 128. Abcam Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 129. Abcam Bicyclic Peptide Drugs Product Portfolios and Specifications Table 130. Abcam Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 131. Abcam Main Business Table 132. Abcam Latest Developments Table 133. Biotium Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 134. Biotium Bicyclic Peptide Drugs Product Portfolios and Specifications Table 135. Biotium Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 136. Biotium Main Business Table 137. Biotium Latest Developments Table 138. Cayman Chemical Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 139. Cayman Chemical Bicyclic Peptide Drugs Product Portfolios and Specifications Table 140. Cayman Chemical Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 141. Cayman Chemical Main Business Table 142. Cayman Chemical Latest Developments Table 143. Apollo Scientific Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 144. Apollo Scientific Bicyclic Peptide Drugs Product Portfolios and Specifications Table 145. Apollo Scientific Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 146. Apollo Scientific Main Business Table 147. Apollo Scientific Latest Developments Table 148. Tocris Bioscience Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 149. Tocris Bioscience Bicyclic Peptide Drugs Product Portfolios and Specifications Table 150. Tocris Bioscience Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 151. Tocris Bioscience Main Business Table 152. Tocris Bioscience Latest Developments Table 153. Ningbo Inno Pharmchem Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 154. Ningbo Inno Pharmchem Bicyclic Peptide Drugs Product Portfolios and Specifications Table 155. Ningbo Inno Pharmchem Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 156. Ningbo Inno Pharmchem Main Business Table 157. Ningbo Inno Pharmchem Latest Developments Table 158. Dayang Chemicals Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 159. Dayang Chemicals Bicyclic Peptide Drugs Product Portfolios and Specifications Table 160. Dayang Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 161. Dayang Chemicals Main Business Table 162. Dayang Chemicals Latest Developments Table 163. Shanghai Lollane Biological Technology Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 164. Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Product Portfolios and Specifications Table 165. Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 166. Shanghai Lollane Biological Technology Main Business Table 167. Shanghai Lollane Biological Technology Latest Developments Table 168. Dalian Meilun Biotech Basic Information, Bicyclic Peptide Drugs Manufacturing Base, Sales Area and Its Competitors Table 169. Dalian Meilun Biotech Bicyclic Peptide Drugs Product Portfolios and Specifications Table 170. Dalian Meilun Biotech Bicyclic Peptide Drugs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024) Table 171. Dalian Meilun Biotech Main Business Table 172. Dalian Meilun Biotech Latest Developments List of Figures Figure 1. Picture of Bicyclic Peptide Drugs Figure 2. Bicyclic Peptide Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Bicyclic Peptide Drugs Sales Growth Rate 2019-2030 (Tons) Figure 7. Global Bicyclic Peptide Drugs Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Bicyclic Peptide Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Bicyclic Peptide Drugs Sales Market Share by Country/Region (2023) Figure 10. Bicyclic Peptide Drugs Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Romidepsin Figure 12. Product Picture of Phalloidin Figure 13. Product Picture of Others Figure 14. Global Bicyclic Peptide Drugs Sales Market Share by Type in 2023 Figure 15. Global Bicyclic Peptide Drugs Revenue Market Share by Type (2019-2024) Figure 16. Bicyclic Peptide Drugs Consumed in Anti-Cancer Figure 17. Global Bicyclic Peptide Drugs Market: Anti-Cancer (2019-2024) & (Tons) Figure 18. Bicyclic Peptide Drugs Consumed in Antibacterial Figure 19. Global Bicyclic Peptide Drugs Market: Antibacterial (2019-2024) & (Tons) Figure 20. Bicyclic Peptide Drugs Consumed in Others Figure 21. Global Bicyclic Peptide Drugs Market: Others (2019-2024) & (Tons) Figure 22. Global Bicyclic Peptide Drugs Sale Market Share by Application (2023) Figure 23. Global Bicyclic Peptide Drugs Revenue Market Share by Application in 2023 Figure 24. Bicyclic Peptide Drugs Sales by Company in 2023 (Tons) Figure 25. Global Bicyclic Peptide Drugs Sales Market Share by Company in 2023 Figure 26. Bicyclic Peptide Drugs Revenue by Company in 2023 ($ millions) Figure 27. Global Bicyclic Peptide Drugs Revenue Market Share by Company in 2023 Figure 28. Global Bicyclic Peptide Drugs Sales Market Share by Geographic Region (2019-2024) Figure 29. Global Bicyclic Peptide Drugs Revenue Market Share by Geographic Region in 2023 Figure 30. Americas Bicyclic Peptide Drugs Sales 2019-2024 (Tons) Figure 31. Americas Bicyclic Peptide Drugs Revenue 2019-2024 ($ millions) Figure 32. APAC Bicyclic Peptide Drugs Sales 2019-2024 (Tons) Figure 33. APAC Bicyclic Peptide Drugs Revenue 2019-2024 ($ millions) Figure 34. Europe Bicyclic Peptide Drugs Sales 2019-2024 (Tons) Figure 35. Europe Bicyclic Peptide Drugs Revenue 2019-2024 ($ millions) Figure 36. Middle East & Africa Bicyclic Peptide Drugs Sales 2019-2024 (Tons) Figure 37. Middle East & Africa Bicyclic Peptide Drugs Revenue 2019-2024 ($ millions) Figure 38. Americas Bicyclic Peptide Drugs Sales Market Share by Country in 2023 Figure 39. Americas Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2024) Figure 40. Americas Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) Figure 41. Americas Bicyclic Peptide Drugs Sales Market Share by Application (2019-2024) Figure 42. United States Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 43. Canada Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 44. Mexico Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 45. Brazil Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 46. APAC Bicyclic Peptide Drugs Sales Market Share by Region in 2023 Figure 47. APAC Bicyclic Peptide Drugs Revenue Market Share by Region (2019-2024) Figure 48. APAC Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) Figure 49. APAC Bicyclic Peptide Drugs Sales Market Share by Application (2019-2024) Figure 50. China Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 51. Japan Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 52. South Korea Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 53. Southeast Asia Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 54. India Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 55. Australia Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 56. China Taiwan Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 57. Europe Bicyclic Peptide Drugs Sales Market Share by Country in 2023 Figure 58. Europe Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2024) Figure 59. Europe Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) Figure 60. Europe Bicyclic Peptide Drugs Sales Market Share by Application (2019-2024) Figure 61. Germany Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 62. France Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 63. UK Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 64. Italy Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 65. Russia Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 66. Middle East & Africa Bicyclic Peptide Drugs Sales Market Share by Country (2019-2024) Figure 67. Middle East & Africa Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024) Figure 68. Middle East & Africa Bicyclic Peptide Drugs Sales Market Share by Application (2019-2024) Figure 69. Egypt Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 70. South Africa Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 71. Israel Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 72. Turkey Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 73. GCC Countries Bicyclic Peptide Drugs Revenue Growth 2019-2024 ($ millions) Figure 74. Manufacturing Cost Structure Analysis of Bicyclic Peptide Drugs in 2023 Figure 75. Manufacturing Process Analysis of Bicyclic Peptide Drugs Figure 76. Industry Chain Structure of Bicyclic Peptide Drugs Figure 77. Channels of Distribution Figure 78. Global Bicyclic Peptide Drugs Sales Market Forecast by Region (2025-2030) Figure 79. Global Bicyclic Peptide Drugs Revenue Market Share Forecast by Region (2025-2030) Figure 80. Global Bicyclic Peptide Drugs Sales Market Share Forecast by Type (2025-2030) Figure 81. Global Bicyclic Peptide Drugs Revenue Market Share Forecast by Type (2025-2030) Figure 82. Global Bicyclic Peptide Drugs Sales Market Share Forecast by Application (2025-2030) Figure 83. Global Bicyclic Peptide Drugs Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Bicycle Therapeutics"|||"Apellis Pharmaceuticals"|||"Merck"|||"Thermo Fisher"|||"ApexBio Technology"|||"BPS Bioscience"|||"Selleck Chemicals"|||"AdooQ BioScience"|||"Cayman Chemical Company"|||"Santa Cruz Biotechnology"|||"TargetMol Chemicals"|||"Abcam"|||"Biotium"|||"Cayman Chemical"|||"Apollo Scientific"|||"Tocris Bioscience"|||"Ningbo Inno Pharmchem"|||"Dayang Chemicals"|||"Shanghai Lollane Biological Technology"|||"Dalian Meilun Biotech"